Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan P Casas

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
International Journal of Epidemiology|February 21, 2008
Commentary: Social class, C-reactive protein and coronary heart diseaseJuan P Casas
Lancet (London, England)|May 22, 2012
Statins for all by the age of 50 years?Shah Ebrahim, Juan P Casas
European Heart Journal|May 2, 2007
The role of infection in cardiovascular disease: more support but many questions remainLiam Smeeth, Juan P Casas, Aroon D Hingorani
Lancet (London, England)|March 6, 2004
Ximelagatran or warfarin in atrial fibrillation?Raymond MacAllister, Aroon D Hingorani, Juan P Casas
European Heart Journal|May 11, 2006
Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease riskAroon D Hingorani, Tina Shah, Juan P Casas
BMJ (Clinical Research Ed.)|August 6, 2011
Putting genomics into practiceMichael V Holmes, Juan P Casas, Aroon D Hingorani
Circulation|June 5, 2003
Regional pathologies and globalization of clinical trials: has the time for regional trials arrived?Juan P Casas, Luz A Cubillos-Garzón, Carlos A Morillo
Plos Medicine|September 7, 2006
Noncommunicable diseases and injuries in Latin America and the Caribbean: time for actionPablo Perel, Juan P Casas, Zulma Ortiz, et al.
Annals of Epidemiology|April 20, 2006
Estimation of bias in nongenetic observational studies using "mendelian triangulation"Leonelo E Bautista, Liam Smeeth, Aroon D Hingorani, et al.
Archives of Neurology|November 10, 2004
Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controlsJuan P Casas, Aroon D Hingorani, Leonelo E Bautista, et al.
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
International Journal of Epidemiology|February 21, 2008
Commentary: Social class, C-reactive protein and coronary heart diseaseJuan P Casas
Lancet (London, England)|May 22, 2012
Statins for all by the age of 50 years?Shah Ebrahim, Juan P Casas
European Heart Journal|May 2, 2007
The role of infection in cardiovascular disease: more support but many questions remainLiam Smeeth, Juan P Casas, Aroon D Hingorani
Lancet (London, England)|March 6, 2004
Ximelagatran or warfarin in atrial fibrillation?Raymond MacAllister, Aroon D Hingorani, Juan P Casas
European Heart Journal|May 11, 2006
Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease riskAroon D Hingorani, Tina Shah, Juan P Casas
BMJ (Clinical Research Ed.)|August 6, 2011
Putting genomics into practiceMichael V Holmes, Juan P Casas, Aroon D Hingorani
Circulation|June 5, 2003
Regional pathologies and globalization of clinical trials: has the time for regional trials arrived?Juan P Casas, Luz A Cubillos-Garzón, Carlos A Morillo
Plos Medicine|September 7, 2006
Noncommunicable diseases and injuries in Latin America and the Caribbean: time for actionPablo Perel, Juan P Casas, Zulma Ortiz, et al.
Annals of Epidemiology|April 20, 2006
Estimation of bias in nongenetic observational studies using "mendelian triangulation"Leonelo E Bautista, Liam Smeeth, Aroon D Hingorani, et al.
Archives of Neurology|November 10, 2004
Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controlsJuan P Casas, Aroon D Hingorani, Leonelo E Bautista, et al.
Pageof 18